Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
John Lamattina Insider Profile
4 Followers
John Lamattina, Director at Ligand Pharma, holds 28.26K shares in Ligand Pharma (Ticker: LGND), holds 66.95K shares in Immunome (Ticker: IMNM), holds 31.38K shares in Larimar Therapeutics (Ticker: LRMR).
Profitable Transactions
2 out of 4 Profitable Transactions
Average Return
-17.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that John Lamattina holds in companies
Most Profitable Insider Trade
The most profitable trade made by John Lamattina
John Lamattina's Trading History
Ligand Pharma
Jun 13, 2023
Director
Uninformative Buy
―
$2.40M
Immunome
Jan 17, 2023
Director
Uninformative Buy
60.50K
$964.12K
Larimar Therapeutics
Jan 28, 2019
Director
Uninformative Buy
47.50K
$233.12K
Pfizer
―
SVP
―
$12.79M
Thermo Fisher
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see John Lamattina's performance on stock
You May Also Like
John Lamattina insider profile FAQ
What is the percentage of profitable transactions made by John Lamattina?
The percentage of profitable transactions made by John Lamattina is 50%.
What is the average return per transaction made by John Lamattina?
The average return per transaction made by John Lamattina is -17.00%.
What stocks does John Lamattina hold?
John Lamattina holds: LGND, IMNM, LRMR, PFE, TMO stocks.
What was John Lamattina’s latest transaction?
John Lamattina latest transaction was an Uninformative Buy of ―.
What was John Lamattina's most profitable transaction?
John Lamattina’s most profitable transaction was an Informative Sell of LGND stock on November 17, 2021. The return on the trade was 25.00%.
What is John Lamattina's role in Ligand Pharma?
John Lamattina's role in Ligand Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.